Literature DB >> 14697313

The potential of GDNF as a treatment for Parkinson's disease.

Carrie B Hurelbrink1, Roger A Barker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697313     DOI: 10.1016/j.expneurol.2003.09.018

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  6 in total

Review 1.  Parkinson's disease and primate research: past, present, and future.

Authors:  E A C Pereira; T Z Aziz
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

2.  Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles.

Authors:  Jung Soo Suk; Junghae Suh; Kokleong Choy; Samuel K Lai; Jie Fu; Justin Hanes
Journal:  Biomaterials       Date:  2006-10       Impact factor: 12.479

3.  GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors.

Authors:  Catarina A R V Gomes; Patrícia F Simões; Paula M Canas; César Quiroz; Ana M Sebastião; Sergi Ferré; Rodrigo A Cunha; Joaquim A Ribeiro
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

4.  Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys.

Authors:  Jamie L Eberling; Adrian P Kells; Philip Pivirotto; Janine Beyer; John Bringas; Howard J Federoff; John Forsayeth; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2009-05       Impact factor: 5.695

Review 5.  Treatment strategies for Parkinson's disease.

Authors:  Hong Yuan; Zhen-Wen Zhang; Li-Wu Liang; Quan Shen; Xiang-Dang Wang; Su-Mei Ren; Hong-Jie Ma; Shu-Jun Jiao; Ping Liu
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

Review 6.  Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier.

Authors:  Débora B Vieira; Lionel F Gamarra
Journal:  Int J Nanomedicine       Date:  2016-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.